Science
Anthropic’s Rare-Disease Grants Turn AI Credits into Scientific Infrastructure
Anthropic’s rare-disease grant program shows how AI credits are becoming a form of scientific infrastructure, not just promotional spend.
Read Article →
2 articles
Anthropic’s rare-disease grant program shows how AI credits are becoming a form of scientific infrastructure, not just promotional spend.
The pharmaceutical industry is undergoing an AI-native transformation. We explore how predictive toxicology and multi-omics are accelerating drug discovery and chemical safety in 2026.